Fusarium moniliforme, IgE, Serum
Use
This test is used for establishing a diagnosis of an allergy to Fusarium moniliforme and helps in defining the allergen responsible for eliciting signs and symptoms. It identifies allergens responsible for allergic responses and/or anaphylactic episodes. Additionally, it confirms sensitization prior to beginning immunotherapy and investigates the specificity of allergic reactions to insect venom allergens, drugs, or chemical allergens.
Special Instructions
Not provided.
Limitations
Testing for IgE antibodies is not useful in patients previously treated with immunotherapy to determine if residual clinical sensitivity exists or in patients where the medical management does not depend upon identification of allergen specificity. False-positive results for IgE antibodies may occur in patients with markedly elevated serum IgE (>2500 kU/L) due to nonspecific binding to allergen solid phases.
FDA ApprovedNew York Approved
Methodology
Immunoassay (Fluorescence Enzyme Immunoassay (FEIA))
Biomarkers
Fusarium moniliforme, IgE
Other
LOINC Codes
- 6121-8 - F moniliforme IgE Qn
- 6121-8 - F moniliforme IgE Qn
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL for every 5 allergens requested
Minimum Volume
For 1 allergen: 0.3 mL; For more than 1 allergen: (0.05 mL x number of allergens) + 0.25 mL deadspace
Container
Preferred: Serum gel; Acceptable: Red top; Submission: Plastic vial
Collection Instructions
Centrifuge and aliquot serum into a plastic vial.
Causes for Rejection
Gross hemolysis: OK; Gross lipemia: OK
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 14 days |
| Frozen | 90 days |